Safety of Soluble Beta-Glucan (SBG) in Treatment of Patients With Non-Hodgkin's Lymphoma
This study has been completed.
Sponsor:
Biotec Pharmacon ASA
Information provided by:
Biotec Pharmacon ASA
ClinicalTrials.gov Identifier:
NCT00533728
First received: September 20, 2007
Last updated: March 2, 2009
Last verified: March 2009
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | March 2009 |
| Primary Completion Date: | February 2009 (Final data collection date for primary outcome measure) |